Search

Search Constraints

You searched for: Author/Creator Baldini, C

Search Results

1. 1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. (23rd October 2018)

2. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018)

3. 296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). (23rd October 2018)

4. 3OApplicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials. (27th February 2019)

5. 49P Thromboembolic risk assessment in patients receiving combination of anti-angiogenic plus anti-PD1 or anti-PD-L1: A descriptive study. (15th December 2019)

6. 54P Applicability of the LIPI score to metastatic microsatellite instability high cancer patients treated with immune checkpoint inhibitors. (15th December 2019)

7. A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. (March 2015)

8. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. (January 2015)

9. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. (January 2015)

10. Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: review of the literature and a cross-sectional prospective experience. Issue 7 (11th June 2018)